z-logo
open-access-imgOpen Access
A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation
Author(s) -
Iram Hussain,
Nivedita Patni,
Masako Ueda,
Ekaterina Sorkina,
Cynthia Melissa Valério,
Elaine Cochran,
Rebecca J. Brown,
Joseph Peeden,
Yulia V. Tikhonovich,
Anatoly Tiulpakov,
Sarah Stender,
Elisabeth Klouda,
Marwan K. Tayeh,
Jeffrey W. Innis,
Anders R.L. Meyer,
Priti Lal,
Amélio F. GodoyMatos,
Milena Gurgel Teles,
Beverley AdamsHuet,
Daniel J. Rader,
Robert A. Hegele,
Elif A Oral,
Abhimanyu Garg
Publication year - 2017
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2017-02078
Subject(s) - lmna , lipodystrophy , progeria , medicine , endocrinology , hypertriglyceridemia , metabolic syndrome , diabetes mellitus , genetics , mutation , biology , triglyceride , immunology , cholesterol , gene , antiretroviral therapy , viral load , human immunodeficiency virus (hiv)
Lamin A/C (LMNA) gene mutations cause a heterogeneous group of progeroid disorders, including Hutchinson-Gilford progeria syndrome, mandibuloacral dysplasia, and atypical progeroid syndrome (APS). Five of the 31 previously reported patients with APS harbored a recurrent de novo heterozygous LMNA p.T10I mutation. All five had generalized lipodystrophy, as well as similar metabolic and clinical features, suggesting a distinct progeroid syndrome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom